These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pathogen-reduction for platelet concentrates. Weber CF; Heim MU Clin Lab; 2011; 57(5-6):293-5. PubMed ID: 21755817 [No Abstract] [Full Text] [Related]
23. Incidence and significance of the bacterial contamination of blood components. Blajchman MA Dev Biol (Basel); 2002; 108():59-67. PubMed ID: 12220143 [TBL] [Abstract][Full Text] [Related]
24. Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop. Klein HG; Glynn SA; Ness PM; Blajchman MA; Transfusion; 2009 Jun; 49(6):1262-8. PubMed ID: 19392769 [TBL] [Abstract][Full Text] [Related]
27. The application of photosensitisers to tropical pathogens in the blood supply. Wainwright M; Baptista MS Photodiagnosis Photodyn Ther; 2011 Sep; 8(3):240-8. PubMed ID: 21864797 [TBL] [Abstract][Full Text] [Related]
28. [Pathogen reduction of blood components: from financial issues to possible long-term consequences]. Canellini G; Wasserfallen JB; Tissot JD Transfus Clin Biol; 2011 Aug; 18(4):493-7. PubMed ID: 21719339 [TBL] [Abstract][Full Text] [Related]
30. Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processes. Bah A; Cardoso M; Seghatchian J; Goodrich RP Transfus Apher Sci; 2018 Oct; 57(5):683-688. PubMed ID: 30220450 [TBL] [Abstract][Full Text] [Related]
31. Pathogen inactivation: a new paradigm for preventing transfusion-transmitted infections. McCullough J Am J Clin Pathol; 2007 Dec; 128(6):945-55. PubMed ID: 18024320 [TBL] [Abstract][Full Text] [Related]
32. [Pathogen inactivation processes applicable to cellular products: the Canadian perspective]. Delage G Transfus Clin Biol; 2011 Aug; 18(4):485-7. PubMed ID: 21715210 [TBL] [Abstract][Full Text] [Related]
33. Will pathogen reduction of blood components harm more people than it helps in developed countries? Hess JR; Pagano MB; Barbeau JD; Johannson PI Transfusion; 2016 May; 56(5):1236-41. PubMed ID: 27167359 [TBL] [Abstract][Full Text] [Related]
34. Inactivation of pathogens in blood and blood products. Ben-Hur E Med Health R I; 1998 Dec; 81(12):396-9. PubMed ID: 9884539 [No Abstract] [Full Text] [Related]
35. Transfusion medicine. Second of two parts--blood conservation. Goodnough LT; Brecher ME; Kanter MH; AuBuchon JP N Engl J Med; 1999 Feb; 340(7):525-33. PubMed ID: 10021474 [No Abstract] [Full Text] [Related]
36. How to improve blood safety with respect to bacterial contaminations? Sireis W; Hourfar MK; Seifried E; Schmidt M Vox Sang; 2012 Jul; 103(1):87-8. PubMed ID: 22220739 [No Abstract] [Full Text] [Related]
38. Advances in decontamination of blood components. Corash L Curr Opin Pediatr; 1995 Feb; 7(1):42-6. PubMed ID: 7728202 [TBL] [Abstract][Full Text] [Related]
39. [Transfusions of blood and blood products and virus infections]. Wróblewska M; Piotrowska E; ĺuczak M Postepy Hig Med Dosw; 2002; 56(2):221-40. PubMed ID: 12107964 [TBL] [Abstract][Full Text] [Related]
40. How new is new: the late sampling strategy with rapid bacterial screening of platelet concentrates? Vollmer T; Schottstedt V; Bux J; Knabbe C; Dreier J Vox Sang; 2012 May; 102(4):365. PubMed ID: 22220625 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]